2013 closes in the sign of continuity for ASAlaser: research and internationalization are the guidelines for the year just ended that, despite the difficult economic situation, has a positive sign. The increase of the revenue (5%), thanks to significant performance of the U.S. market in the "human" and "veterinary" sector, the growth of the staff(+10%) with employments in technical, quality assurance and marketing sectors, consolidation of already loyal markets (Russia and USA) and opening to new representatives (Vietnam and Bolivia) have allowed ASAlaser to continue on its growth. MLS® Laser Therapy and Hilterapia® have been able to carve out a leading role, especially abroad, thanks to the recognition of value of professionals and international luminaries and the opening of new fields of application that, in 2014, will have their full development (MLS® in the treatment of temporo-mandibular disorders and craniofacial pain). To mark the 30th year of the company have also contributed other factors, intended to have further expansion in short and medium term: the development of a new line of devices for Veterinary Medicine (MphiVet ORANGE) and the interest in this sector by European countries (Germany in particular) and South America ones goes in this direction.
The positive result for 2013 is also signed by successes in sports linked to the renewed partnership with Clinica Mobile for the MotoGP and SBK and Italian Fencing Federation. «We are projected into the future - says Lucio Zaghetto, ASAlaser CEO - thanks to positive confirmations during the last year: by now loyal partners have reiterated their desire to go on working with us and new references have shown their enthusiasm in starting a new path with ASA. The sensibility of new markets to our therapeutic proposals for human and veterinary sectors encourages us to continue on a path always been focused on innovation». Innovation that is encoded also in the development of non-conventional communication tools for the electro medical field. «If in 2012 we have realized the first App for Ipad of our sector, which has received significant recognition during Medica 2013 - says Roberto Marchesini, ASAlaser Managing Director – last year we have focused our attention on Comics, creating the first one dedicated to an instrumental therapy. On 2014 we will work for the launch of the application for Android. ASAlaser is a company that is always looking ahead in every area».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.